Literature DB >> 24814492

Reply: regarding the effect of dabigatran plasma concentrations.

Paul A Reilly, Stuart J Connolly, Salim Yusuf, John W Eikelboom, Michael D Ezekowitz, Lars Wallentin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24814492     DOI： 10.1016/j.jacc.2014.04.012

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  2 in total

1.  Does the FDA Owe Us an Explanation?

Authors:  James A Reiffel
Journal:  J Atr Fibrillation       Date:  2015-10-31

2.  Unexpected excessive apixaban exposure: case report of a patient with polymorphisms of multiple apixaban elimination pathways.

Authors:  Andrea Huppertz; Caspar Grond-Ginsbach; Chris Dumschat; Kathrin I Foerster; Jürgen Burhenne; Johanna Weiss; David Czock; Jan C Purrucker; Timolaos Rizos; Walter E Haefeli
Journal:  BMC Pharmacol Toxicol       Date:  2019-08-29       Impact factor: 2.483
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.